Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/12404| Title: | Herpes simplex - a new approach |
| Authors: | Borg, Ronnie |
| Keywords: | Herpes simplex Herpes simplex virus Acyclovir Herpesvirus diseases -- Chemotherapy |
| Issue Date: | 1983 |
| Publisher: | Medi-Scope |
| Citation: | Borg, R. (1983). Herpes simplex - a new approach. Medi-Scope,1, 24 |
| Abstract: | Herpes simplex is a viral disease caused by herpes simplex viruses that are characterized by their ability to take permanent residence in the host causing infections. Acyclovir is the first selective medication that is used particularly against herpes viruses by means of a two stage mechanism, namely, by a selective concentration in infected cells and by inhibition of herpes DNA synthesis. Since acyclovir is relatively insoluble and largely excreted by the kidney, care is therefore recommended for patients who are dehydrated or who have poor kidney function. |
| Description: | Condensed from an article in the Postgraduate Medical Digest No. 8 December 1981. Acyclovir is marketed by the Wellcome Foundation Ltd. under the name of Zovirax. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/12404 |
| Appears in Collections: | Medi-Scope, Issue 1 Medi-Scope, Issue 1 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Herpes Simplex-A New Approach.pdf | 77.37 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.